Related Experiment Videos
Protein kinase C mu is negatively regulated by 14-3-3 signal transduction proteins
1Institute of Cell Biology and Immunology, University of Stuttgart, Allmandring 31, 70569 Stuttgart, Germany.
Abstract:
Recent studies have documented direct interaction between 14-3-3 proteins and key molecules in signal transduction pathways like Ras, Cbl, and protein kinases. In T cells, the 14-3-3tau isoform has been shown to associate with protein kinase C theta and to negatively regulate interleukin-2 secretion. Here we present data that 14-3-3tau interacts with protein kinase C mu (PKCmu), a subtype that differs from other PKC members in structure and activation mechanisms. Specific interaction of PKCmu and 14-3-3tau can be shown in the T cell line Jurkat by immunocoprecipitiation and by pulldown assays of either endogenous or overexpressed proteins using PKCmu-specific antibodies and GST-14-3-3 fusion proteins, respectively. Using PKCmu deletion mutants, the 14-3-3tau binding region is mapped within the regulatory C1 domain. Binding of 14-3-3tau to PKCmu is significantly enhanced upon phorbol ester stimulation of PKCmu kinase activity in Jurkat cells and occurs via a Cbl-like serine containing consensus motif. However, 14-3-3tau is not a substrate of PKCmu. In contrast 14-3-3tau strongly down-regulates PKCmu kinase activity in vitro. Moreover, overexpression of 14-3-3tau significantly reduced phorbol ester induced activation of PKCmu kinase activity in intact cells. We therefore conclude that 14-3-3tau is a negative regulator of PKCmu in T cells.
Insights
14-3-3tau protein interacts with protein kinase C mu (PKCmu) in T cells. This interaction negatively regulates PKCmu kinase activity, identifying 14-3-3tau as a key inhibitor.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- 14-3-3 proteins are crucial in signal transduction.
- The 14-3-3tau isoform regulates T cell signaling, including interleukin-2 secretion via protein kinase C theta.
- Protein kinase C mu (PKCmu) is a distinct PKC subtype with unique activation mechanisms.
Purpose of the Study:
- To investigate the interaction between 14-3-3tau and PKCmu.
- To determine the functional consequence of this interaction on PKCmu activity in T cells.
Main Methods:
- Immunoprecipitation and pulldown assays in Jurkat T cells.
- Analysis of PKCmu deletion mutants to map binding sites.
- In vitro kinase assays and overexpression studies in intact cells.
Main Results:
- 14-3-3tau specifically binds to the C1 domain of PKCmu.
- Binding is enhanced upon phorbol ester stimulation and occurs via a Cbl-like motif.
- 14-3-3tau inhibits PKCmu kinase activity both in vitro and in intact T cells.
Conclusions:
- 14-3-3tau directly interacts with PKCmu.
- 14-3-3tau functions as a negative regulator of PKCmu activity in T cells.